Literature DB >> 23535923

Anticancer IGF1R classes take more knocks.

Malini Guha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23535923     DOI： 10.1038/nrd3992

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  27 in total

1.  CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers.

Authors:  Andreas M Heilmann; Rushika M Perera; Veronika Ecker; Brandon N Nicolay; Nabeel Bardeesy; Cyril H Benes; Nicholas J Dyson
Journal:  Cancer Res       Date:  2014-07-01       Impact factor: 12.701

Review 2.  Can we unlock the potential of IGF-1R inhibition in cancer therapy?

Authors:  Helen King; Tamara Aleksic; Paul Haluska; Valentine M Macaulay
Journal:  Cancer Treat Rev       Date:  2014-08-04       Impact factor: 12.111

Review 3.  The role of HTS in drug discovery at the University of Michigan.

Authors:  Martha J Larsen; Scott D Larsen; Andrew Fribley; Jolanta Grembecka; Kristoff Homan; Anna Mapp; Andrew Haak; Zaneta Nikolovska-Coleska; Jeanne A Stuckey; Duxin Sun; David H Sherman
Journal:  Comb Chem High Throughput Screen       Date:  2014-03       Impact factor: 1.339

Review 4.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

Review 5.  Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancer.

Authors:  Darshil T Jhaveri; Lei Zheng; Elizabeth M Jaffee
Journal:  Semin Oncol       Date:  2014-07-22       Impact factor: 4.929

6.  Highly specific role of the insulin receptor in breast cancer progression.

Authors:  Ran Rostoker; Sagi Abelson; Keren Bitton-Worms; Inna Genkin; Sarit Ben-Shmuel; Maria Dakwar; Zila Shen Orr; Avishay Caspi; Maty Tzukerman; Derek LeRoith
Journal:  Endocr Relat Cancer       Date:  2015-04       Impact factor: 5.678

7.  IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice.

Authors:  Gordon Moody; Pedro J Beltran; Petia Mitchell; Elaina Cajulis; Young-Ah Chung; David Hwang; Richard Kendall; Robert Radinsky; Pinchas Cohen; Frank J Calzone
Journal:  J Endocrinol       Date:  2014-03-17       Impact factor: 4.286

Review 8.  Impact of targeting insulin-like growth factor signaling in head and neck cancers.

Authors:  Kirsten H Limesand; Alejandro Martinez Chibly; Andrew Fribley
Journal:  Growth Horm IGF Res       Date:  2013-06-29       Impact factor: 2.372

9.  Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.

Authors:  Christina L Roland; Caitlin D May; Kelsey L Watson; Ghadah A Al Sannaa; Sean P Dineen; Rachel Feig; Sharon Landers; Davis R Ingram; Wei-Lien Wang; B Ashleigh Guadagnolo; Barry Feig; Kelly K Hunt; Janice N Cormier; Alexander J Lazar; Keila E Torres
Journal:  Ann Surg Oncol       Date:  2016-02-03       Impact factor: 5.344

Review 10.  The Actions of IGF-1 in the Growth Plate and Its Role in Postnatal Bone Elongation.

Authors:  Holly L Racine; Maria A Serrat
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.